Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory ITP”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07811622
What this trial is testing

Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Immune Thrombocytopenia (ITP)
Nanjing Miracle Biotechnology Co., Ltd. 24
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT05562882
What this trial is testing

A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 60
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Not applicableLooking for participantsNCT07206823
What this trial is testing

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

Who this might be right for
Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06352281
What this trial is testing

Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)

Who this might be right for
ITP - Immune Thrombocytopenia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 10
Early research (Phase 1)Looking for participantsNCT07072247
What this trial is testing

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

Who this might be right for
Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 9
Testing effectiveness (Phase 2)Study completedNCT03524612
What this trial is testing

Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Novartis Pharmaceuticals 105
Very early researchLooking for participantsNCT07174843
What this trial is testing

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Who this might be right for
Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Not Yet RecruitingNCT07765966
What this trial is testing

Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias

Who this might be right for
Immune Thrombocytopenia (ITP)
RiboX Therapeutics Ltd. 27
Testing effectiveness (Phase 2)UnknownNCT00107913
What this trial is testing

Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura

Who this might be right for
Autoimmune Thrombocytopenic Purpura
Hematology and Oncology Specialists 10
Early research (Phase 1)Looking for participantsNCT06943937
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd. 36
Not applicableWithdrawnNCT06813157
What this trial is testing

Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Guangzhou Bio-gene Technology Co., Ltd
Not applicableStudy completedNCT01971684
What this trial is testing

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

Who this might be right for
Immune Thrombocytopenia
Boston Children's Hospital 120
Early research (Phase 1)Not Yet RecruitingNCT07622329
What this trial is testing

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenic Purpura, Immune
The General Hospital of Western Theater Command 4
Testing effectiveness (Phase 2)Study completedNCT00706342
What this trial is testing

Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Rigel Pharmaceuticals 18
Large-scale testing (Phase 3)UnknownNCT02877212
What this trial is testing

Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75
Large-scale testing (Phase 3)Study completedNCT01525836
What this trial is testing

RhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University 123
Early research (Phase 1)Looking for participantsNCT06787989
What this trial is testing

BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases

Who this might be right for
Refractory Immune Cytopenia
iCell Gene Therapeutics 20
Not applicableLooking for participantsNCT06973356
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital 18
Next Page